JP2006505530A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505530A5
JP2006505530A5 JP2004532517A JP2004532517A JP2006505530A5 JP 2006505530 A5 JP2006505530 A5 JP 2006505530A5 JP 2004532517 A JP2004532517 A JP 2004532517A JP 2004532517 A JP2004532517 A JP 2004532517A JP 2006505530 A5 JP2006505530 A5 JP 2006505530A5
Authority
JP
Japan
Prior art keywords
azabicyclo
oct
carboxamide
octane
thiophene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004532517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505530A (ja
Filing date
Publication date
Priority claimed from SE0202598A external-priority patent/SE0202598D0/xx
Application filed filed Critical
Publication of JP2006505530A publication Critical patent/JP2006505530A/ja
Publication of JP2006505530A5 publication Critical patent/JP2006505530A5/ja
Abandoned legal-status Critical Current

Links

JP2004532517A 2002-09-02 2003-09-01 アルファ−７ニコチン受容体作用剤およびスタチンの組み合わせ Abandoned JP2006505530A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0202598A SE0202598D0 (sv) 2002-09-02 2002-09-02 Alpha-7 Nicotinic receptor agonists and statins in combination
PCT/SE2003/001352 WO2004019947A1 (en) 2002-09-02 2003-09-01 Alpha-7 nicotinic receptor agonists and statins in combination

Publications (2)

Publication Number Publication Date
JP2006505530A JP2006505530A (ja) 2006-02-16
JP2006505530A5 true JP2006505530A5 (enExample) 2006-10-19

Family

ID=20288874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004532517A Abandoned JP2006505530A (ja) 2002-09-02 2003-09-01 アルファ−７ニコチン受容体作用剤およびスタチンの組み合わせ

Country Status (12)

Country Link
US (2) US20050256146A1 (enExample)
EP (1) EP1545537B9 (enExample)
JP (1) JP2006505530A (enExample)
AT (1) ATE358485T1 (enExample)
AU (1) AU2003256203A1 (enExample)
DE (1) DE60313004T2 (enExample)
DK (1) DK1545537T3 (enExample)
ES (1) ES2283860T3 (enExample)
PT (1) PT1545537E (enExample)
SE (1) SE0202598D0 (enExample)
SI (1) SI1545537T1 (enExample)
WO (1) WO2004019947A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
WO2009017454A1 (en) * 2007-07-30 2009-02-05 Astrazeneca Ab New therapeutic combination of a gsk3 inhibitor and an a7-nicotinic agonist 960
ES2402084T3 (es) 2008-06-20 2013-04-26 Astrazeneca Ab Derivado de dibenzotiazepina y sus usos
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues
CN103221411B (zh) 2010-05-17 2016-05-11 富瑞姆制药公司 (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型
WO2012007500A2 (de) 2010-07-15 2012-01-19 Bayer Cropscience Ag Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
TWI634119B (zh) * 2011-03-18 2018-09-01 美商健臻公司 葡萄糖神經醯胺合成酶抑制劑
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
JPWO2013161871A1 (ja) * 2012-04-25 2015-12-24 興和株式会社 Ｔｌｒ阻害作用を有するチオフェン誘導体
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
ES2694299T3 (es) 2013-02-07 2018-12-19 Heptares Therapeutics Limited Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4
EA029430B1 (ru) 2013-06-21 2018-03-30 Такеда Фармасьютикл Компани Лимитед Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
CN103923105B (zh) * 2014-04-17 2016-08-24 北京大学 2-中氮茚甲酰胺类化合物及其制备和用途
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
US20210255202A1 (en) * 2018-06-13 2021-08-19 Michael R. D'Andrea Methods and dosing regimens for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild congnitive impairment
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54375C2 (uk) * 1994-08-24 2003-03-17 Астра Актієболаг Спіро-азабіциклічні сполуки, способи їх одержання та фармацевтична композиція
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds
SE9903996D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
WO2002017358A2 (en) * 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6569865B2 (en) * 2001-06-01 2003-05-27 Astrazeneca Ab Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
US20050222122A1 (en) * 2002-04-02 2005-10-06 Sean Lilienfeld Statin therapy for enhancing cognitive maintenance
JP2006510662A (ja) * 2002-12-11 2006-03-30 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー α７ニコチン性アセチルコリン受容体アゴニストとその他の化合物との組合せによる疾患の治療
BRPI0508771A (pt) * 2004-03-25 2007-08-14 Memory Pharm Corp indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos

Similar Documents

Publication Publication Date Title
JP2006505530A5 (enExample)
US20090192180A1 (en) Alpha-7 Nicotinic Receptor Agonists and Statins In Combination
RU2002118302A (ru) Новые биарилкарбоксамиды
CA2514135A1 (en) 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
CA2938184C (en) Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof
JP2003514818A5 (enExample)
JP2002523502A5 (enExample)
RU2008148902A (ru) Производные имидазол-пиримидина для лечения заболеваний, связанных с киназой гликогенсинтазы 3 (gsk3)
HRP20130007T1 (hr) Lijeäśenje kognitivnih poremeä†aja pomoä†u (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamida i njegovih farmaceutski prihvatljivih soli
WO2000010551A3 (en) Methods of using and compositions comprising dopamine reuptake inhibitors
JP2014526435A5 (enExample)
JP2012523437A5 (enExample)
JP2004511512A5 (enExample)
HRP20171793T1 (hr) Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-kloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidroklorid monohidrata
AU2007271186C1 (en) Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
JP2008526861A5 (enExample)
JP2009514802A5 (enExample)
JP2015522018A5 (enExample)
JP2014503568A (ja) ニコチン酸アセチルコリン受容体α７活性化因子の使用
RU2007134414A (ru) Бензоксазолкарбоксамиды для лечения индуцированной химиотерапией тошноты и рвоты (cini) и синдрома раздраженного кишечника с преобладанием диареи (ibs-d)
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
JP2003522171A5 (enExample)
CN105263492B (zh) α7烟碱型乙酰胆碱受体激动剂在治疗发作性睡病中的应用
JP2005510482A5 (ja) 線維筋痛症候群の治療用医薬
JP2010524906A5 (enExample)